User Reviews for Alkeran

Genetic mutations known as BRCA1 and BRCA2 raise the risk of getting ovarian cancer, but new research shows that those same mutations may boost a woman's odds...

CAMBRIDGE, Mass., January 23, 2012–Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced...

PHILADELPHIA (December 28, 2011) – Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be...

Two new studies suggest that the drug Avastin may lengthen progression-free survival by about four months for women with ovarian cancer. What isn't clear yet...

Mutations in a gene called DICER are associated with rare, seemingly unrelated ovarian, uterine and testicular cancers, a new study finds. The Canadian...